Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.3500 (-1.55%) ($6.3000 - $6.5100) on Thu. Sep. 29, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.11% (three month average) | RSI | 14 | Latest Price | $6.3500(-1.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.2% a day on average for past five trading days. | Weekly Trend | CGEN declines -2.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) EWG(4%) TBT(4%) URA(4%) BOTZ(3%) XRT(3%) | Factors Impacting CGEN price | CGEN will decline at least -1.055% in a week (0% probabilities). VCSH(-8%) VCIT(-8%) USO(-8%) TIP(-7%) BNDX(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.055% (StdDev 2.11%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-1.05(-116.54%) | Resistance Level | $6.83 | 5 Day Moving Average | $6.56(-3.2%) | 10 Day Moving Average | $6.62(-4.08%) | 20 Day Moving Average | $6.83(-7.03%) | To recent high | -14.3% | To recent low | 0% | Market Cap | $525m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |